Literature DB >> 6379790

Surgery of retinal detachment with proliferative vitreoretinopathy.

R G Michels.   

Abstract

Surgical treatment of retinal detachment complicated by proliferative vitreoretinopathy (PVR) depends on understanding both the pathoanatomy of the structural changes and the biologic time course of the intraocular proliferative process. Successful surgery is dependent on treating both the traction and rhegmatogenous components. Vitreous surgery is used to relieve the transvitreal traction and to remove epiretinal membranes causing fixed folding of the posterior retina. A broad and high scleral buckle is used to close all retinal breaks and to relieve remaining anteroperipheral vitreous and epiretinal membrane traction that cannot be relieved by vitrectomy. Vitreous surgery is best done after the proliferative process has run its biologic time course to minimize recurrence of epiretinal membranes. Therefore, staged procedures may be used in selected cases by first modifying the scleral buckle to treat the rhegmatogenous component followed later by definitive vitreous surgery. The principles and techniques of managing retinal detachment with PVR are described.

Entities:  

Mesh:

Year:  1984        PMID: 6379790     DOI: 10.1097/00006982-198400420-00001

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  10 in total

1.  Cytotoxic effects of antiproliferative agents on human retinal glial cells in vitro.

Authors:  J Cai; R Wei; X Ma; H Zhu; Y Li
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

2.  Design features and surgical use of a cannulated extrusion needle.

Authors:  H W Flynn; W G Lee; J M Parel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

3.  Retinal detachment: is reparative surgery always mandatory?

Authors:  W H Jarrett
Journal:  Trans Am Ophthalmol Soc       Date:  1988

Review 4.  Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment.

Authors:  D G Charteris
Journal:  Br J Ophthalmol       Date:  1995-10       Impact factor: 4.638

5.  Constricting retroretinal membranes associated with traumatic retinal detachments.

Authors:  B Daicker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1985       Impact factor: 3.117

6.  Use of perfluorocarbon liquids in proliferative vitreoretinopathy: results and complications.

Authors:  U Stolba; S Binder; M Velikay; P Datlinger; A Wedrich
Journal:  Br J Ophthalmol       Date:  1995-12       Impact factor: 4.638

7.  The combined use of perfluorohexyloctane (F6H8) and silicone oil as an intraocular tamponade in the treatment of severe retinal detachment.

Authors:  Stanislao Rizzo; Federica Genovesi-Ebert; Claudia Belting
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-21       Impact factor: 3.117

8.  Surgical repair of primary non-complex rhegmatogenous retinal detachment in the modern era of small-gauge vitrectomy.

Authors:  Omar Moinuddin; Rebhi O Abuzaitoun; Min W Hwang; Sanjana K Sathrasala; Xing D Chen; Joshua D Stein; Mark W Johnson; David N Zacks; Thomas J Wubben; Cagri G Besirli
Journal:  BMJ Open Ophthalmol       Date:  2021-02-25

9.  Antifouling Super Water Absorbent Supramolecular Polymer Hydrogel as an Artificial Vitreous Body.

Authors:  Hongbo Wang; Yuanhao Wu; Chunyan Cui; Jianhai Yang; Wenguang Liu
Journal:  Adv Sci (Weinh)       Date:  2018-09-25       Impact factor: 16.806

Review 10.  Managing PVR in the Era of Small Gauge Surgery.

Authors:  Manish Nagpal; Rakesh Juneja; Sham Talati
Journal:  J Ophthalmol       Date:  2021-12-04       Impact factor: 1.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.